These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 2820631)
1. Immune response to oral polio vaccine in patients with IgA glomerulonephritis. Leinikki PO; Mustonen J; Pasternack A Clin Exp Immunol; 1987 Apr; 68(1):33-8. PubMed ID: 2820631 [TBL] [Abstract][Full Text] [Related]
2. Humoral immune response in patients with IgA and IgM glomerulonephritis. Pasternack A; Mustonen J; Leinikki P Clin Exp Immunol; 1986 Jan; 63(1):228-33. PubMed ID: 3955883 [TBL] [Abstract][Full Text] [Related]
3. Systemic immune response to oral polio immunization in patients with IgA nephropathy. Waldo FB; Cochran AM J Clin Lab Immunol; 1989 Mar; 28(3):109-14. PubMed ID: 2738908 [TBL] [Abstract][Full Text] [Related]
4. Altered humoral immunity against cytomegalovirus and Epstein-Barr virus without detectable virus antigens and virus-DNA in the glomeruli of patients with IGA nephropathy in remission phase. Nagy J; Haikin H; Sarov B; Háber A; Kun L; Sarov I Acta Microbiol Immunol Hung; 1995; 42(2):179-87. PubMed ID: 7551711 [TBL] [Abstract][Full Text] [Related]
5. A cross-sectional sero epidemiological prevalence of polio virus antibodies post-immunization with three doses of TOPV. Tswana SA; Berejena C; Moyo SR; Mudyarabikwa O Cent Afr J Med; 1994 Nov; 40(11):303-5. PubMed ID: 7859270 [TBL] [Abstract][Full Text] [Related]
6. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus. Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050 [TBL] [Abstract][Full Text] [Related]
7. Preexisting poliovirus-specific IgA in the circulation correlates with protection against virus excretion in the elderly. Buisman AM; Abbink F; Schepp RM; Sonsma JA; Herremans T; Kimman TG J Infect Dis; 2008 Mar; 197(5):698-706. PubMed ID: 18279050 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity in monkeys of two polio type 3 seed viruses (SO + 2 and SOR + 1) presently used for production of oral polio vaccine. Sokhey J; Sharma B; Singh H J Commun Dis; 1989 Dec; 21(4):301-8. PubMed ID: 2561635 [TBL] [Abstract][Full Text] [Related]
9. Mucosal and systemic immunity against poliovirus in mice transgenic for the poliovirus receptor: the poliovirus receptor is necessary for a virus-specific mucosal IgA response. Buisman AM; Sonsma JA; Kimman TG; Koopmans MP J Infect Dis; 2000 Mar; 181(3):815-23. PubMed ID: 10720499 [TBL] [Abstract][Full Text] [Related]
10. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice. Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698 [TBL] [Abstract][Full Text] [Related]
11. In vivo alteration of antibody production in patients with IgA nephropathy. Endoh M; Suga T; Miura M; Tomino Y; Nomoto Y; Sakai H Clin Exp Immunol; 1984 Sep; 57(3):564-70. PubMed ID: 6380836 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes. Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770 [TBL] [Abstract][Full Text] [Related]
13. Humoral immunity against viral antigens in insulin-dependent diabetes mellitus (IDDM): altered IgA class immune response against mumps virus. Hyöty H; Huupponen T; Leinikki P Clin Exp Immunol; 1985 Apr; 60(1):139-44. PubMed ID: 4006299 [TBL] [Abstract][Full Text] [Related]
14. Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine. Taffs RE; Enterline JC; Rusmil K; Muhilal ; Suwardi SS; Rustama D; Djatnika ; Cobra C; Semba RD; Cohen N; Asher DM Bull World Health Organ; 1999; 77(6):484-91. PubMed ID: 10427933 [TBL] [Abstract][Full Text] [Related]
15. The immunoglobulin class responses to oral poliovaccine in coeliac disease. Mawhinney H; Love AH Clin Exp Immunol; 1975 Sep; 21(3):399-406. PubMed ID: 1106924 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of anti-polio and anti-HSV IgA pre-plasma cell response in blood following parenteral immunization with tetanus-diphtheria vaccine. Fernandes JR; Wasserman S; Snider DP Vaccine; 2010 Feb; 28(6):1493-8. PubMed ID: 20003921 [TBL] [Abstract][Full Text] [Related]
17. Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children. Samoilovich E; Roivainen M; Titov LP; Hovi T J Med Virol; 2003 Oct; 71(2):274-80. PubMed ID: 12938203 [TBL] [Abstract][Full Text] [Related]
18. [Surveillance of levels of neutralizing antibodies against poliovirus among children aged 0-3 in rural areas of Anhui Province]. Shen Y; Zhao Y; Liu D Zhonghua Yu Fang Yi Xue Za Zhi; 1995 Nov; 29(6):335-8. PubMed ID: 8697935 [TBL] [Abstract][Full Text] [Related]
19. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine. Ciarlet M; Sani-Grosso R; Yuan G; Liu GF; Heaton PM; Gottesdiener KM; Arredondo JL; Schödel F Pediatr Infect Dis J; 2008 Oct; 27(10):874-80. PubMed ID: 18756184 [TBL] [Abstract][Full Text] [Related]
20. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion. Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]